Background illustration for clinical trials search

Paid Clinical Trials Little Rock

Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

for
ADHD
Location: Little Rock AR, Memphis TN, Jackson MS, Friendswood TX,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 12 - 17

Code: NCT07717892

Phase3, Recruiting
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

for
ADHD
Location: Little Rock AR, Memphis TN, Jackson MS, Friendswood TX,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 6 - 11

Code: NCT07717879

Phase3, Recruiting
Active & Responsive

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

for
Stomatitis
Location: Little Rock AR, Hot Springs AR, Elizabethtown KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07357597

Recruiting
Active & Responsive

A Study to Evaluate the Effect of KarXT on Urological Safety

for
Schizophrenia
Location: Little Rock AR, DeSoto TX, Chicago IL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT07221877

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

for
Mania, Bipolar Disorder
Location: Little Rock AR, Bentonville AR, Richardson TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT07140913

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

for
Major Depressive Disorder (MDD)
Location: Little Rock AR, Richardson TX, Plano TX,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06830044

Phase3, Recruiting
Active & Responsive

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

for
Schizophrenia
Location: Bryant AR, Oklahoma City OK, Franklin TN, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07379827

Recruiting
Active & Responsive

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

for
Nonsegmental Vitiligo
Location: Bryant AR, Plano TX, Baton Rouge LA, New Orleans LA,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT07108283

Phase2, Recruiting
Active & Responsive

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Bryant AR, DeSoto TX, Atlanta GA, Mason OH, Tampa FL,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT06911112

Phase3, Recruiting
Active & ResponsiveNew

Prenatal Exercise and Glucose Regulation

for
Gestational Diabetes Mellitus,
Location: Conway AR
Sponsor: University of Central Arkansas

Sex: Female

Age: 18 - 35

Code: NCT07802262

Recruiting
Active & Responsive

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis (AD)
Location: Hot Springs AR, Arlington TX, Birmingham AL, Houston TX,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07298395

Phase2, Recruiting
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Sherwood AR, Shreveport LA, Jackson TN, Jackson MS,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase2, Phase3, Recruiting
Active & Responsive

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

for
Advanced Breast Cancer, Early Breast Cancer
Location: Hot Springs AR, New Orleans LA, Springfield IL,
Sponsor: TerSera Therapeutics LLC

Sex: Female

Age: 18 - 55

Code: NCT07310420

Phase1, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Hot Springs AR, Kansas City MO, Houston TX,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06722235

Phase3, Recruiting
Active & Responsive

A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

for
EGFR Inhibitor-associated Rash
Location: Hot Springs AR, Houston TX, Gahanna OH, Fairfax VA,
Sponsor: Azitra Inc.

Sex: All

Age: 18+

Code: NCT06830863

Phase1, Phase2, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Little Rock AR, Jonesboro AR, Southhaven MS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Little Rock AR, Fort Smith AR, Branson MO,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase3, Recruiting

Placement of Nasogastric Tubes for Gastric Decompression in Patients With Bronchiolitis

for
Bronchiolitis
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 1

Code: NCT04480970

Recruiting

Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs

for
Respiratory Distress Syndrome in Premature Infant
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0

Code: NCT04326270

Recruiting

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

for
Lymphatic Malformation
Location: Little Rock AR, Nashville TN, Birmingham AL,
Sponsor: Protara Therapeutics

Sex: All

Age: 0 - 18

Code: NCT05871970

Phase2, Recruiting